GSK opens new regional headquarters for Asia in Singapore
30 October 2017
• Purpose-built headquarters to support the pharmaceutical, vaccines and consumer healthcare businesses across multiple regions
• GSK Asia House will build right capabilities to better meet Asia’s diverse healthcare needs and capture growth.
Singapore, 30 October 2017 – GSK today celebrated the official opening of GSK Asia House (GSKAH), the new commercial hub for more than half of its worldwide healthcare operations. The Singapore headquarters will house the senior regional leadership teams of the Pharmaceuticals, Vaccines and Consumer Healthcare businesses and will work alongside the US hub to support its Global Headquarters in the UK to manage commercial activities around the world.
Located at One-North in the Rochester Park area of Singapore, it will enable GSK to better anticipate and respond to diverse healthcare needs across different markets, placing GSK in a leading position to support patients and consumers.
The inauguration ceremony was officiated by Tharman Shanmugaratnam, Singapore’s Deputy Prime Minister and Coordinating Minister for Economic and Social Policies as the Guest-of-Honour together with Emma Walmsley, Chief Executive Officer of GSK Plc, in the presence of government officials, representatives from local health institutions, academic partners and GSK employees.
Emma Walmsley said: “Asia represents an important growth opportunity for GSK and our investment in GSK Asia House reinforces our long-term commitment to delivering for patients, consumers and employees in Singapore and Asia.”
GSK Asia House building photos
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com/about-us.